Ester-based precursors to increase the bioavailability of quercetin

Journal of Medicinal Chemistry

Volumn 50, Issue 2, 2007, Pages 241-253

  Biasutto, Lucia ^a   Marotta, Ester ^a   De Marchi, Umberto ^a   Zoratti, Mario ^a,b   Paradisi, Cristina ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3' (4 AMINOBENZOIC ACID)QUERCETIN ESTER; 3' (4 AMINOBUTANOIC ACID)QUERCETIN ESTER; 3' (6 AMINOHEXANOIC ACID)TETRAACETYLQUERCETIN ESTER; 3' DEXTRO ALANINE QUERCETIN ESTER; 3' DEXTRO ALANINE TETRAACETYLQUERCETIN ESTER; AMINO ACID; ESTER DERIVATIVE; POLYPHENOL DERIVATIVE; QUERCETIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CLONE; CELL STRAIN; CELL STRAIN CACO 2; CELL TYPE; CONJUGATION; DEACYLATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG METABOLISM; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; DRUG TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MONOLAYER CULTURE; NONHUMAN; ULTRAVIOLET SPECTROSCOPY;

ADSORPTION; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; DOGS; DRUG STABILITY; ESTERS; HUMANS; PRODRUGS; QUERCETIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33846413961     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm060912x     Document Type: Article

References (98)

1. Bors, W.; Michel, C.; Stettmaier, K. Structure-activity relationship governing antioxidant capacities of plant polyphenols. Methods Enzymol. 2001, 335, 166-180.
2. Frei, B.; Higdon, J. V. Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J. Nutr. 2003, 133, 3275S-3284S.
3. Sang, S.; Hou, Z.; Lambert, H. D.; Yang, C. S. Redox properties of tea polyphenols and related biological activities. Antioxid. Redox Signaling 2005, 7, 1704-1714.
4. Higdon, J. V.; Frei, B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. Nutr. 2003, 43, 89-143.
5. Kundu, J. K.; Surh, Y. J. Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets. Mutat. Res. 2004, 555, 65-80.
6. Bode, A. M.; Dong, Z. Cancer prevention by food factors through targeting signal transduction pathways. Nutrition 2004, 20, 89-94.
7. Manson, M. M.; Farmer, P. B.; Gescher, A.; Steward, W. P. Innovative agents in cancer prevention. Recent Results Cancer Res. 2005, 166, 257-275.
8. Aggarwal, B. B.; Shishodia, S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 2006, 71, 1397-1421.
9. Yang, C. S.; Sang, S.; Lambert, J. D.; Hou, Z.; Ju, J.; Lu, G. Possible mechanisms of the cancer-preventive activities of green tea. Mol. Nutr. Food. Res. 2006, 50, 170-175.
10. Stoclet, J. C.; Chataigneau, T.; Ndiaye, M.; Oak, M. H.; El Bedoui, J.; Chataigneau, M.; Schini-Kerth, V. B. Vascular protection by dietary polyphenols. Eur. J. Pharmacol. 2004, 500, 299-313.
11. Vita, J. A. Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am. J. Clin. Nutr. 2005, 81 (Suppl. 1), 292S-297S.
12. Labinskyy, N.; Csiszar, A., Veress, G.; Stef, G.; Pacher, P.; Oroszi, G.; Wu, J.; Ungvari, Z. Vascular dysfunction in aging: potential effects of resveratrol, an anti-inflammatory phytoestrogen. Curr. Med. Chem. 2006, 13, 989-996.
13. Youdim, K. A.; Shukitt-Hale, B.; Joseph, J. A. Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system. Free Radical Biol. Med. 2004, 37, 1683-1693.
14. Joseph, J. A.; Shukitt-Hale, B.; Casadesus, G. Reversing the deleterious effects of aging on neuronal communication and behavior: beneficial properties of fruit polyphenolic compounds. Am. J. Clin. Nutr. 2005, 81 (Suppl. 1), 313S-316S.
15. Baur, J. A.; Sinclair, D. A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discovery 2006, 5, 493-506.
16. Baur, J. A.; Pearson, K. J.; Price, N. L.; Jamieson, H. A.; Kalra, A.; Prabhu, V. V.; Allard, J. S.; Lopez-Lluch, G.; Lewis, K.; Pistell, P. J.; Poosala, S., Becker, K. G.; Boss, O.; Gwinn, D.; Wang, M.; Ramaswamy, S.; Fishbein, K. W.; Spencer, R. G.; Lakatta, E. G.; Le Couleur, D.; Shaw, R. J.; Navas, P.; Puigserver, P.; Ingram D. K.; de Cabo, R.; Sinclair, D. A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444, 337-342.
17. Vina, J.; Borras, C.; Gambini, J.; Sastre, J.; Pallardo, F. V. Why females live longer than males? Importance of the upregulation of longevity-associated genes by oestrogenic compounds. FEBS Lett. 2005, 579, 2541-2545.
18. Crespy, V.; Williamson, G. A review of the health effects of green tea catechins in in vivo animal models. J. Nutr. 2004, 134, 3431S-3440S.
19. Arts, I. C.; Hollman, P. C. Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 2005, 81 (Suppl. 1), 317S-325S.
20. Williamson, G.; Manach, C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am. J. Clin. Nutr. 2005, 81 (Suppl. 1), 243S-255S.
21. Sirtori, C. R.; Arnoldi, A.; Johnson, S. K. Phytoestrogens: end of a tale? Ann. Med. 2005, 37, 423-438.
22. Cassidy, A.; Albertazzi, P.; Lise Nielsen, I.; Hall, W.; Williamson, G.; Tetens, I.; Atkins, S.; Cross, H.; Manios, Y.; Wolk, A.; Steiner, C.; Branca, F. Critical review of health effects of soybean phytooestrogens in post-menopausal women. Proc. Nutr. Soc. 2006, 65, 76-92.
23. de Lorgeril, M.; Salen, P.; Paillard, F.; Laporte, F.; Boucher, F.; de Leiris, J. Mediterranean diet and the French paradox: two distinct biogeographic concepts for one consolidated scientific theory on the role of nutrition in coronary heart disease. Cardiovasc. Res. 2002, 54, 503-515.
24. Ferrieres, J. The French paradox: lessons for other countries. Heart 2004, 90, 107-111.
25. Park, O. J.; Surh, Y. J. Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies. Toxicol. Lett. 2004, 150, 43-56.
26. Ravindranath, M. H.; Muthugounder, S.; Presser, N.; Viswanathan, S. Anticancer therapeutic potential of soy isoflavone, genistein. Adv. Exp. Med. Biol. 2004, 546, 121-165.
27. Dell'Agli, M.; Buscialà, A.; Bosisio, E. Vascular effects of wine polyphenols. Cardiovasc. Res. 2004, 63, 593-602.
28. Zern, T. L.; Fernandez, M. L. Cardioprotective effects of dietary polyphenols. J. Nutr. 2005, 135, 2291-2294.
29. Balk, E.; Chung, M.; Chew, P.; Ip, S.; Raman, G.; Kupelnick, B.; Tatsioni, A.; Sun, Y.; Devine, D.; Lau, J. Effects of soy on health outcomes. Evidence Rep. Technol. Assess. (Summ.) 2005, 126, 1-8.
30. Trock, B. J.; Hilakivi-Clarke, L.; Clarke, R. Meta-analysis of soy intake and breast cancer risk. J. Natl. Cancer Inst. 2006, 98, 459-471.
31. Martinez, M. E.; Thomson, C. A.; Smith-Warner, S. A. Soy and breast cancer: the controversy continues. J. Natl. Cancer Inst. 2006, 98, 430-431.
32. Messina, M. Resolving the soy-breast cancer controversy. J. Am. Diet Assoc. 2006, 106, 363-364.
33. Chai, P. C.; Long, L. H.; Halliwell, B. Contribution of hydrogen peroxide to the cytotoxicity of green tea and red wines. Biochem. Biophys. Res. Commun. 2003, 304, 650-654.
34. Halliwell, B. Oxidative stress in cell culture: an under-appreciated problem? FEBS Lett. 2003, 540, 3-6.
35. Choi, E. J.; Chee, K. M.; Lee, B. H. Anti- and prooxidant effects of chronic quercetin administration in rats. Eur. J. Pharmacol. 2003, 482, 281-285.
36. Dröge, W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002, 82, 47-95.
37. Mandel, S.; Weinreb, O.; Amit, T.; Youdim, M. B. Cell signaling pathways in neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3- gallate: implications for neurodegenerative diseases. J. Neurochem. 2004, 88, 1555-1569.
38. Kroon, P. A.; Clifford, M. N.; Crozier, A.; Day, A. J.; Donovan, J. L.; Manach, C.; Williamson, G. How should we assess the effects of exposure to dietary polyphenols in vitro? Am. J. Clin. Nutr. 2004, 80, 15-21.
39. Scalbert, A.; Manach, C.; Morand, C.; Remesy, C.; Jimenez, L. Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr. 2005, 45, 287-306.
40. O'Leary, K. A.; Day, A. J.; Needs, P. W.; Sly, W. S.; O'Brien, N. M.; Williamson, G. Flavonoid glucuronides are substrates for human liver beta-glucuronidase. FEBS Lett. 2001, 503, 103-106.
41. O'Leary, K. A.; Day, A. J.; Needs, P. W.; Mellon, F. A.; O'Brien, N. M.; Williamson, G. Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human β-glucoronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem. Pharmacol. 2003, 65, 479-491.
42. Spencer, J. P.; Kuhnle, G. G.; Williams, R. J.; Rice-Evans, C. Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochem. J. 2003, 372, 173-181.
43. Walle, T. Absorption and metabolism of flavonoids. Free Radical Biol. Med. 2004, 36, 829-837.
44. Manach, C.; Donovan, J. L. Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radical Res. 2004, 38, 771-785.
45. Manach, C.; Scalbert, A.; Morand, C.; Remesy, C.; Jimenez, L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727-747.
46. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Rémésy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81 (Suppl.), 230S-242S.
47. Day, A. J.; Mellon, F.; Barron, D.; Sarrazin, G.; Morgan, M. R.; Williamson, G. Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radical Res. 2001, 35, 941-952.
48. Wittig, J.; Herderich, M.; Graefe, E. U.; Veit, M. Identification of quercetin glucuronides in human plasma by high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr., B 2001, 753, 237-243.
49. 14C]quercetin-4′-glucoside. J. Agric. Food Chem. 2002, 50, 6902-6909.
50. 14C-labelled flavonol metabolites by high-performance liquid chromatography-radiocounting and tandem mass spectrometry. J. Chromatogr., A 2003, 1007, 21-29.
51. Mullen, W.; Boitier, A.; Stewart, A. J.; Crozier, A. Flavonoid metabolites in human plasma and urine after the consumption of red onions: analysis by liquid chromatography with photodiode array and full scan tandem mass spectrometric detection. J. Chromatogr., A 2004, 1058, 163-168.
52. Van der Woude, H.; Boersma, M. G.; Vervoort, J.; Rietjiens, I. M. Identification of 14 quercetin phase II mono- and mixed conjugates and their formation by rat and human phase II in vitro model systems. Chem. Res. Toxicol. 2004, 17, 1520-1530.
53. Murota, K.; Terao, J. Quercetin appears in the lymph of unanesthetized rats as its phase II metabolites after administered into the stomach. FEBS Lett. 2005, 579, 5343-5346.
54. Williamson, G.; Barron, D.; Shimoi, K.; Terao, J. In vitro biological properties of flavonoid conjugates found in vivo. Free Radical Res. 2005, 39, 457-469.
55. Donnini, S.; Finetti, F.; Lusini, L.; Morbidelli, L.; Cheynier, V.; Barron, D.; Williamson, G.; Waltenberger, J.; Ziehe, M. Divergent effects of quercetin conjugates on angiogenesis. Br. J. Nutr. 2006, 95, 1016-1023.
56. Liederer, B. M.; Borchardt, R. T. Enzymes involved in the bioconversion of ester-based prodrugs. J. Pharm. Sci. 2006, 95, 1177-1195.
57. Potter, P. M.; Wadkins, R. M. Carboxylesterases: detoxifying enzymes and targets for drug therapy. Curr. Med. Chem. 2006, 13, 1045-1054.
58. Redinbo, M. R.; Potter, P. M. Mammalian Carboxylesterases: from drug targets to protein therapeutics. Drug Discovery Today 2005, 10, 313-325.
59. Beaumont, K.; Webster, R.; Gardner, I.; Dack, K. Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist. Curr. Drug Metab. 2003, 4, 461-485.
60. De Clercq, E.; Field, H. J. Antiviral prodrugs-the development of successful prodrug strategies for antiviral chemotherapy. Br. J. Pharmacol. 2006, 147, 1-11.
61. Lam, W. H.; Kazi, A.; Kuhn, D. J.; Chow, L. M.; Chan, A. S.; Dou, Q. P.; Chan, T. H. A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG]. Bioorg. Med. Chem. 2004, 12, 5587-5593.
62. Kuhn, D.; Lam, W. H.; Kazi, A.; Daniel, K. G.; Song, S.; Chow, L. M.; Chan, T. H.; Dou, Q. P. Synthetic peracetate tea polyphenols as potent proteasome inhibitors and apoptosis inducers in human cancer cells. Front. Biosci. 2005, 10, 1010-1023.
63. Picq, M.; Prigent, A. F.; Nemoz, G.; Andre, A. C.; Pacheco, H. Pentasubstituted quercetin analogues as selective inhibitors of paniculate 3′,5′-cyclic-AMP phosphodiesterase from rat brain. J. Med. Chem. 1982, 25, 1192-1198.
64. Iwase, Y.; Takemura, Y.; Ju-ichi, M.; Mukainaka, T.; Ichiishi, E.; Ito, C.; Furukawa, H.; Yano, M.; Tokuda, H.; Nishino, H. Inhibitory effect of flavonoid derivatives on Epstein-Barr virus activation and two-stage carcinogenesis of skin tumors. Cancer Lett. 2001, 173, 105-109.
65. Kohli, E.; Raj, H. G.; Kumari, R.; Rohil, V.; Kaushik, N. K.; Prasad, A. K.; Parmar, V. S. Comparison of the prevention of aflatoxin b(1)-induced genotoxicity by quercetin and quercetin pentaacetate. Bioorg. Med. Chem. Lett. 2002, 12, 2579-2582.
66. Chen, Y. C.; Shen, S. C.; Lee, W. R.; Hou, W. C.; Yang, L. L.; Lee, T. J. Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages. J. Cell. Biochem. 2001, 82, 537-548.
67. Mulholland, P. J.; Ferry, D. R.; Anderson, D.; Hussain, S. A.; Young, A. M.; Cook, J. E.; Hodgkin, E.; Seymour, L. W.; Kerr, D. J. Preclinical study of QC12, a water-soluble, pro-drug of quercetin. Ann. Oncol. 2001, 12, 245-248.
68. Crespy, V.; Morand, C.; Manach, C.; Besson, C.; Demigne, C.; Rémésy, C. Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen. Am. J. Physiol. 1999, 277, G120-G126.
69. Day, A. J.; DuPont, M. S.; Ridley, S.; Rhodes, M.; Rhodes, M. J. C.; Morgan, M. R. A.; Williamson, G. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β-glucosidase activity. FEBS Lett. 1998, 436, 71-75.
70. Day, A. J.; Bao, Y.; Morgan, M. R.; Williamson, G. Conjugation position of quercetin glucuronides and effect on biological activity. Free Radical Biol. Med. 2000, 29, 1234-1243.
71. Day, A. J.; Gee, J. M.; DuPont, M. S.; Johnson, I. T.; Williamson, G. Absorption of quercetin-3-glucoside and quercetin-4′-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter. Biochem. Pharmacol. 2003, 65, 1199-1206.
72. Petri, N.; Tannergren, C.; Holst, B.; Mellon, F. A.; Bao, Y.; Plumb, G. W.; Bacon, J.; O'Leary, K. A.; Kroon, P. A.; Knutson, L.; Forsell, P.; Eriksson, T.; Lennernas, H.; Williamson, G. Absorption/ metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo. Drug Metab. Dispos. 2003, 31, 805-813.
73. Walgren, R. A.; Walle, U. K.; Walle, T. Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochem. Pharmacol. 1998, 55, 1721-1727.
74. Murota, K.; Shimizu, S.; Chujo, H.; Moon, J. H.; Terao, J. Efficiency of absorption and metabolic conversion of quercetin and its glucosides in human intestinal cell line Caco-2. Arch. Biochem. Biophys. 2000, 384, 391-397.
75. Song, X.; Lorenzi, P. L.; Landowski, C. P.; Vig, B. S.; Hilfinger, J. M.; Amidon, G. L. Amino acid ester prodrugs of the anticancer agent gemcitabine: synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transport. Mol. Pharm. 2005, 2, 157-167.
76. Landowski, C. P.; Song, X.; Lorenzi, P. L.; Hilfinger, J. M.; Amidon, G. L. Floxuridine amino acid ester prodrugs: enhancing Caco-2 permeability and resistance to glycosidic bond metabolism. Pharm. Res. 2005, 22, 1510-1518.
77. Li, F.; Hong, L.; Mau, C. L.; Chan, R.; Hendricks, T.; Dvorak, C.; Yee, C.; Harris, J.; Alfredson, T. Transport of levovirin prodrugs in the human intestinal Caco-2 cell line. J. Pharm. Sci. 2006, 95, 1318-1325.
78. Vig, B. S.; Lorenzi, P. J.; Mittal, S.; Landowski, C. P.; Shin, H. C.; Mosberg, H. I.; Hilfinger, J. M.; Amidon, G. L. Amino acid ester prodrugs of floxuridine: synthesis and effects of structure, stereochemistry, and site of esterification on the rate of hydrolysis. Pharm. Res. 2003, 20, 1381-1388.
79. Lorenzi, P. L.; Landowski, C. P.; Song, X.; Borysko, K. Z.; Breitenbach, J. M.; Kim, J. S.; Hilfinger, J. M.; Townsend, L. B.; Drach, J. C.; Amidon, G. L. Amino acid ester prodrugs of 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl) benzimidazole enhance metabolic stability in vitro and in vivo. J. Pharmacol. Exp. Ther. 2005, 314, 883-890.
80. Jovanovic, S. V.; Steenken, S.; Tosic, M.; Marjanovic, B.; Simic, M. G. Flavonoids as antioxidants. J. Am. Chem. Soc. 1994, 116, 4846-4851.
81. Timbola, A.; de Souza, C. D.; Giacomelli, C.; Spinelli, A. Electrochemical oxidation of quercetin in hydro-alcoholic solution. J. Braz. Chem. Soc. 2006, 17, 139-148.
82. (a) Dihal, A. A.; Woutersen, R. A.; van Ommen, B.; Rietjens, I. M.; Stierum, R. H. Modulatory effects of quercetin on proliferation and differentiation of the human colorectal cell line Caco-2. Cancer Lett. 2006, 238, 248-259.
83. (b) Murota, K.; Shimizu, S.; Miyamoto, S.; Izumi, T.; Obata, A.; Kikuchi, M.; Terao, J. Unique uptake and transport of isoflavone aglycones by human intestinal Caco-2 cells: comparison of isoflavonoids and flavonoids. J. Nutr. 2002, 132, 1956-1961.
84. Capon, B.; Ghosh, B. C. The mechanism of the hydrolysis of phenyl salicylate and catechol monobenzoate in the presence and absence of borate ions. J. Chem. Soc. B 1966, 472-478.
85. Metodiewa, D.; Jaiswal, A. K.; Cenas, N.; Dickancaite, E.; Segura-Aguilar, J. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radical Biol. Med. 1999, 26, 107-116.
86. Boulton, D. W.; Walle, U. K.; Walle, T. Fate of the flavonoid quercetin in human cell lines: chemical instability and metabolism. J. Pharm. Pharmacol. 1999, 51, 353-359.
87. Bors, W.; Michel, C. Chemistry of the antioxidant effects of polyphenols. Ann. N.Y. Acad. Sci. 2002, 957, 57-69.
88. Li, B.; Sedlacek, M.; Manoharan, I.; Boopathy, R.; Duysen, E. G.; Masson, P.; Lockridge, O. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem. Pharmacol. 2005, 70, 1673-1684.
89. Ma, S. F.; Anraku, M.; Iwao, Y.; Yamasaki, K.; Kragh-Hansen, U.; Yamaotsu, N.; Hirono, S.; Ikeda, T.; Otagiri, M. Hydrolysis of angiotensin II receptor blocker prodrug olmesartan medoxomil by human serum albumin and identification of its catalytic active sites. Drug Metab. Dispos. 2005, 33, 1911-1919.
90. Fiorani, M.; Accorsi, A.; Cantoni, O. Human red blood cells as a natural flavonoid reservoir. Free Radical Res. 2003, 37, 1331-1338.
91. Kitson, T. M. Spectrophotometric and kinetic studies on the binding of the bioflavonoid quercetin to bovine serum albumin. Biosci. Biotechnol. Biochem. 2004, 68, 2165-2170.
92. Kahle, K.; Kraus, M.; Scheppach, W.; Richling, E. Colonic availability of apple polyphenols-a study in ileostomy subjects. Mol. Nutr. Food Res. 2005, 49, 1143-1150.
93. Imai, T.; Imoto, M.; Sakamoto, H.; Hashimoto, M. Identification of esterases expressed in Caco-2 cells and effects of their hydrolyzing activity in predicting human intestinal absorption. Drug Metab. Dispos. 2005, 33, 1185-1190.
94. Furuse, M.; Furuse, K.; Sasaki, H.; Tsukita, S. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J. Cell Biol. 2001, 153, 263-272.
95. Jepson, M. A.; Lang, T. F.; Reed, K. A.; Simmons, N. L. Evidence for a rapid, direct effect on epithelial monolayer integrity and transepithelial transport in response to Salmonella invasion. Pfluegers Arch. 1996, 432, 225-233.
96. Peixoto, E. B.; Collares-Buzato, C. B. Modulation of the epithelial barrier by dexamethasone and prolactin in cultured Madin-Darby canine kidney (MDCK) cells. Cell Biol. Int. 2006, 30, 101-113.
97. Vastag, M.; Neuhofer, W.; Nagel, W.; Beck, F. X. Ammonium affects tight junctions and the cytoskeleton in MDCK cells. Pfluegers Arch. 2005, 449, 384-391.
98. Zhang, L.; Zheng, Y.; Chow, M. S. S.; Zuo, Z. Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model. Int. J. Pharm. 2004, 287, 1-12.